Dr Antje Neubert
Research Fellow, Centre for Paediatric Pharmacy Research
Tel: +44 (0)20 7874 1537
Fax: +44 (0)20 7387 5693
Email: 
Areas of Expertise
Paediatric Pharmacoepidemiology & Drugs Safety, EU-Project Management
Biography
Dr. Antje Neubert graduated from the University of Erlangen-Nuremberg in Germany where she also obtained her PhD. Before joining The School of Pharmacy, Dr Neubert held a postdoctoral position at the Department for Experimental and Clinical Pharmacology and Toxicology at FAU Erlangen-Nuremberg in Germany where she was involved in computerised monitoring of drug therapy in neonates. In January 2006 she joined the Centre for Paediatric Pharmacy Research where she is leading the UK activities of the EU Commissions-funded Network of Excellence in Childrens Medicines Research ''TEDDY''. Antje Neubert is also Chief Investigator of ADVISE (www.paediatric-adr.com), an international study on adverse drug reactions in children.
Selected Publications
2006 -
Neubert A, Verhamme K, Murray ML, Picelli G, Hsia Y, Sen FE, Giaquinto C, Ceci A, Sturkenboom MC, Wong ICK: The Prescribing of Analgesics and Non-Steroidal Anti-Inflammatory Drugs in Paediatric Primary Care in the UK, Italy and the Netherlands, submitted ADC, August 2009
Viner RM, Hsia Y, Neubert A, Wong IC. Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study. Br J Clin Pharmacol. 2009 Dec;68(6):844-51.
Zopf Y, Rabe C, Neubert A, Janson C, Brune K, Hahn EG, Dormann H. Gender-based differences in drug prescription: relation to adverse drug reactions. Pharmacology. 2009;84(6):333-9. Epub 2009 Oct 17.
Hsia Y, Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Sen F, Giaquinto C,Ceci A, Wong IC; on behalf of the TEDDY Network of Excellence. Comparison of antiepileptic drug prescribing in children in three European countries. Epilepsia. 2009 Oct 8. [Epub ahead of print]
Neubert A, Lukas K, Leis T, Dormann H, Brune K, Rascher W. Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis. Eur J Clin Pharmacol. 2009 Sep 16. [Epub ahead of print]
Hsia Y, Neubert AC, Rani F, Viner RM, Hindmarsh PC, Wong IC. An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database. Br J Clin Pharmacol 2009 67: 242-9.
Sturkenboom MC, Verhamme KM, Nicolosi A, Murray ML, Neubert A, Caudri D, Picelli G, Sen EF, Giaquinto C, Cantarutti L, Baiardi P, Felisi MG, Ceci A, Wong IC; TEDDY European Network of Excellence. Drug use in children: cohort study in three European countries. BMJ. 2008 Nov 24;337:a2245. doi: 10.1136/bmj.a2245.
Zopf Y, Rabe C, Neubert A, Hahn EG, Dormann H. Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf. 2008;31(9):789-98.
Zopf Y, Rabe C, Neubert A, Gassmann KG, Rascher W, Hahn EG, Brune K, Dormann H. Women encounter ADRs more often than do men. Eur J Clin Pharmacol. 2008 Oct;64(10):999-1004. Epub 2008 Jul 5.
Neubert A, Planner C, Cranswick N The new European regulation on pediatric medicines: safety and ethics perspectives. Paediatr Drugs. 2008;10(3):147-9. (Editorial)
Neubert A, Wong IC, Bonifazi A, Catapano M, Felisi M, Baiardi P, Giaquinto C, Knibbe CA, Sturkenboom MC, Ghaleb MA, Ceci A., Defining Off-label and Unlicensed Use of Medicines for Children: Results of a Delphi survey, Pharmacol Res. 2008 Nov-Dec;58(5-6):316-22
Neubert A, Sturkenboom MC, Murray ML et al.: Databases for pediatric medicine research in Europe--assessment and critical appraisal. Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1155-67.
Eberl S, Renner B, Neubert A, Reisig M, Bachmakov I, König J, Dörje F, Mürdter TE, Ackermann A, Dormann H, Gassmann KG, Hahn EG, Zierhut S, Brune K, Fromm MF: Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies. Clin Pharmacokinet. 2007;46(12):1039-49.
Neubert A, Rascher W, Unerwünschte Arzneimittelwirkungen bei Kindern: Erkennen und Bewerten, Monatsschr Kinderheilk, Vol 155, 8, August, 2007 (Review)
Neubert A, Dormann H, Weiss J, Criegee-Rieck M, Ackermann A, Levy M et al. Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients? Eur J Clin Pharmacol 2006; 62(11):959-965.
2000-2005
Cheremina O, Bachmakov I, Neubert A, Brune K, Fromm MF, Hinz B.: Simultaneous determination of oxycodone and its major metabolite, noroxycodone, in human plasma by high-performance liquid chromatography., Biomed Chromatogr. 2005 May 26,
Egger T, Dormann H, Ahne G, Pahl A, Runge U, Azaz-Livshits T, Neubert A, Criegee-Rieck M, Gassmann KG, Brune K.: Cytochrome p450 polymorphisms in geriatric patients: impact on adverse drug reactions--a pilot study., Drugs Aging. 2005;22(3):265-72.
Neubert A, Dormann H, Weiss J, Criegee-Rieck M, Egger T, Rascher W, Brune K, Hinz B: The impact of unlicensed and off-labeled drugs on adverse drug reactions in pediatric patients, Drug Saf. 2004;27(13):1059-67
Dormann H, Neubert A, Criegee-Rieck M, Egger T, Radespiel-Troger M, Azaz-Livshits T, Levy M, Brune K, Hahn EG.: Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med. 2004 Jun;255(6):653-63
Dormann H, Criegee-Rieck M, Neubert A, Egger T, Levy M, Hahn EG, Brune K.: Implementation of a computer-assisted monitoring system for the detection of adverse drug reactions in gastroenterology. Aliment Pharmacol Ther. 2004 Feb 1;19(3):303-9
Dormann H, Criegee-Rieck M, Neubert A, Egger T, Geise A, Krebs S, Schneider T, Levy M, Hahn E, Brune, K: Lack of awareness of community-acquired adverse drug reactions upon hospital admission: dimensions and consequences of a dilemma. Drug Saf 2003;26(5):353-62
T. Egger, H. Dormann, G. Ahne, U. Runge, A. Neubert, M. Criegee-Rieck, K.G. Gassmann, K. Brune: Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging 2003;20 (10):769-76
Weiss J, Krebs S, Hoffmann C, Werner U, Neubert A, Brune K, Rascher W.: Survey of Adverse Drug Reactions on a Pediatric Ward: A Strategy for Early and Detailed Detection. Pediatrics 2002 Aug;110:254-7
Brune K, Neubert A.: Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspective. Clin Exp Rheumatol. 2001 Nov-Dec;19 (6 Suppl 25):S51-7